Develop and manufacture non-invasive continuous glucose monitoring (CGM) systems. Now — the numbers.
angles, checked one by one.
The 2 that stand out are on screen; the rest are not shown.
The council scores out of 10; report-card grades are out of 100.
Trading Liquidity: The shares change hands too rarely for smooth trading.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Our checks did not surface a specific strength to highlight here.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At last year’s rate of cash burn, the cash lasts about 1.1 years. After that, the company needs to find new money.
The stock trades 100% below its five-year peak.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: revenue and profit, the growth trend, earnings execution, the revenue breakdown.